Varian Medical Systems

<!--StartFragment --> Varian Medical Shares Jump
10.17.2005, 12:56 PM

Shares of Varian Medical Systems Inc. jumped more than 9 percent Monday after the maker of X-rays and cancer treatments announced new products and said strong demand for its radiation therapy technologies boosted net order growth during the fourth fiscal quarter.

The company's shares rose $3.58, or 9.7 percent, to $40.38 in afternoon trading on the New York Stock Exchange. Trading volume reached 2.5 million, compared with the average of about 900,000. In the past 52 weeks, Varian shares have traded between a low of $31.65 and a high of $43.99.

The Palo Alto, Calif.-based company said that demand for its new radiation therapy products will increase net orders for the quarter by about 18 percent compared with the same period a year ago.

The company also unveiled its new software, ARIA Oncology Information Management System, which can be used to manage cancer treatment centers, as well as radiation and oncology departments, without the use of film or paper.

At a meeting last week of the American Society for Therapeutic Radiology and Oncology, Varian introduced a technology, called Dynamic Adaptive Radiotherapy, which uses image data from patients' tumor size, shape and position to adapt cancer treatment as needed.

"It means using technology to deliver the right dose to the right place at the right time, every time, even when the targeted tumor moves, shrinks, or changes shape," said Dow Wilson, president of Varian's Oncology Systems business. "The idea is to keep the treatment beam focused on the tumor at all times, and do the best possible job of protecting normal healthy tissues."

Varian will announce fourth-quarter earnings and its 2006 outlook on Oct. 26.

 

quelle : forbes

<!--StartFragment --> VARIAN MEDICAL SYSTEMS - New York Stock Exchange: VAR (NEW charting help)

<!--VITALS="app:interactivecharting lic:destination sale:kek web:kjb ops:ccn tech:cdt"-->

Enter Symbol or Keyword: Time Frame:   1-day2 days5 days10 days----------1 month2 months3 months6 monthsYTD1 year2 years3 years4 years5 years1 decadeAll Data Additional chart controls  VAR - Varian Med Sys Inc (NYSE) 3:07 PM ET, 10/17/2005  Frequency: Price Display: Start Date: End Date: Size: 1-Minute5-Minute15-MinuteHourly----------DailyWeeklyMonthlyQuarterlyYearly Hide PriceHLCOHLCCandlestickMountainBar ChartsDotCloseLogarithmic StandardLarge Compare to Index: Compare to Symbol(s): Moving Average: Days: <None>SMASMA (2-Line)SMA (3-Line)EMAEMA (2-Line)EMA (3-Line) Upper Indicator: <None>DJIANASDAQS&P 500Russell 2000----------InternetBroker/DealersOil & GasGold & SilverUtilitiesTransportationAirlines <None>MA EnvelopesBollinger BandsParabolic SARVolume by PricePrice Channel----------Show SplitsShow EarningsShow DividendsShow All Events----------A/D Line Lower Indicator 1: Lower Indicator 2: Lower Indicator 3:   VolumeVolume+RSIMACDOBVFast StochasticSlow StochasticROCWilliams %RMoney FlowDMIVol AccumulationVolatility FastVolatility SlowMomentumUlt Oscillator% Short InterestRolling EPSP/E RatioP/E RangesRolling DividendYield----------Up/Down RatioArms Index (TRIN)A/D Line (Breadth)A/D Line (Daily)----------% Compare <None>VolumeVolume+RSIMACDOBVFast StochasticSlow StochasticROCWilliams %RMoney FlowDMIVol AccumulationVolatility FastVolatility SlowMomentumUlt Oscillator% Short InterestRolling EPSP/E RatioP/E RangesRolling DividendYield----------Up/Down RatioArms Index (TRIN)A/D Line (Breadth)A/D Line (Daily)----------% Compare <None>VolumeVolume+RSIMACDOBVFast StochasticSlow StochasticROCWilliams %RMoney FlowDMIVol AccumulationVolatility FastVolatility SlowMomentumUlt Oscillator% Short InterestRolling EPSP/E RatioP/E RangesRolling DividendYield----------Up/Down RatioArms Index (TRIN)A/D Line (Breadth)A/D Line (Daily)----------% Compare Das war ein Blitzstart heute! Da versagt jede Charttechnik, bei solchen News!

 

<!--StartFragment --> Varian Names Guertin As President, COO
08.24.2005, 09:24 AM

Varian Medical Systems Inc. on Wednesday said it named Chief Operating Officer Timothy E. Guertin to the additional role of president.

Dow R. Wilson, who was hired as president and corporate vice president in January, was appointed as executive vice president for the corporation.

Guertin, 56, has served as executive vice president and COO since January. Before that, the 30-year Varian veteran was president of oncology systems for 15 years.

<!--/story--><!-- story controls -->

---

E-mail | Comments | E-Mail Newsletters | RSS

---

<>News Headlines | More From Forbes.com | Special Reports 
 

http://www.forbes.com/search/results.jhtml?MT=Varian&sort=&aname=&author=&date=&pub=forbes.com%2Cmagazine%2Cglobal%2Cfyi%2Casap%2Cbest%2Cbow%2Cap%2Cpinnacor%2Cafx Zum einstieg sollte man erst warten bis es charttechnisch wieder aufwärtsgeht.

<!--StartFragment --> 

VAR - Varian Med Sys Inc (NYSE)

2:54 PM ET, 7/29/2005

<!--StartFragment --> Varian Medical 3Q Profit Rises 20 Pct.
07.27.2005, 05:18 PM

Varian Medical Systems Inc. on Wednesday reported third-quarter profit grew 20 percent as revenue and orders were boosted by demand for its cancer therapy systems.

The company said quarterly net income rose to $51.1 million, or 37 cents per share, from $42.7 million, or 30 cents per share, a year earlier. Revenue grew 14 percent to $346.6 million from $303.1 million a year ago.

Varian said earnings would have been reduced by $7.3 million in the latest quarter if it had elected to recognize stock compensation costs, and earnings per would have been 32 cents per share.

Analysts expected earnings of 36 cents per share on revenue of $344.7 million, according to a Thomson Financial survey.

Quarterly net orders climbed 14 percent to $373.4 million, while backlog totaled nearly $1.08 billion at the end of the quarter, up 19 percent from a year ago.

"The company had a solid quarter with gains in net orders and revenues helped by accelerating adoption of our new technologies in radiation therapy and X-ray imaging," said Richard M. Levy, chairman and chief executive, in a statement. "Demand for new, more precise, and cost effective cancer treatment technology, including image-guided radiation therapy and stereotactic radiotherapy, is robust and adoption is proceeding at an unprecedented pace."

Varian said it still expects fiscal 2005 earnings per share growth of about 26 percent, compared with earnings of $1.18 per share in fiscal 2004. That guidance implies full-year earnings of about $1.49 per share. The company estimates revenue growth of about 12 percent over fiscal 2004 revenue of $1.2 billion.

The company said fiscal 2006 earnings per share should grow at a mid-teens rate before stock option expensing, and revenue should rise by about 13 percent from fiscal 2005.

Analysts expect earnings of $1.48 per share on $1.39 billion in revenue for fiscal 2005, and $1.69 per share on revenue of $1.57 billion for fiscal 2006.

Varian Medical shares closed up $1.21, or 3.1 percent, at $39.81 on the New York Stock Exchange.